bmiMD
bmiMD sells physician-formulated GLP-1 weight-management protocols, compounded tirzepatide and semaglutide injections, plus supporting supplements (B-complex, magnesium, probiotics). All medication is shipped frozen from U.S. pharmacies; plans start around $299 for a 4-week starter dose and rise to $599 for the highest maintenance strength. The brand is online-only: patients complete a telehealth intake, upload labs, and receive doorstep delivery if prescribed.
The company differentiates by bundling unlimited provider messaging, nutrition coaching, and dose-adjustment visits into the drug price—no separate app fees. Medication is compounded in small batches to order, letting bmiMD offer two vial strengths not found in standard starter pens and ship in temperature-stable cold packs that keep potency for 72 h. A 90-day outcomes guarantee—free month if weight loss is under 5 %—is heavily promoted on TikTok and Instagram.
Core buyers are 28-55-year-old professionals (70 % female) with ≥25 BMI who want clinical-grade loss without sitting in a clinic. They value transparent pricing, on-demand texting with an NP, and the discretion of home delivery over branded injectables advertised on TV. Many report choosing bmiMD after insurance denied name-brand GLP-1 coverage.
bmiMD competes with telehealth platforms, med-spas, and compounding pharmacies that market similar peptides. It undercuts cash-pay retail prices by 20-30 % while wrapping physician oversight, coaching, and cold-chain logistics into one subscription, positioning itself as the fastest route from online consult to doorstep medication without sacrificing medical supervision.
Clinical-grade weight loss delivered frozen to your door, no clinic required
Visit site
Science and Humans
Science and Humans is a direct-to-consumer tele-wellness company that focuses on doctor-prescribed longevity and metabolic-health protocols. The core menu is GLP-1 receptor agonist programs (semaglutide and tirzepatide), compounded with B-vitamins or carnitine, priced USD 199-399 per 4-week supply—mid-range between retail pharmacy and concierge clinics. All consultations, prescriptions and refill shipments are handled through the site’s HIPAA-compliant portal; no physical retail.
The brand differentiates by bundling medication with at-home metabolic kits (continuous glucose monitors, gut-microbiome and epigenetic age tests) and unlimited physician chat. Dosing is algorithmically adjusted from patient-uploaded biomarker data, a protocol the company calls “precision longevity therapy.” Same-day pharmacy compounding and overnight cold-chain delivery are marketed as faster than traditional mail-order peers.
Primary users are 30-55-year-old North American professionals who already bio-track (Oura, Levels) and want pharmacological leverage on weight, A1c and biological-age metrics. Messaging emphasizes scientific rigor, transparency and patient agency, aligning with quantified-self and evidence-based wellness subcultures.
Competitors include telehealth diet-clinics, compounded-peptide start-ups and functional-medicine practices. Science and Humans counters by integrating prescription drug therapy with multi-omics testing and continuous feedback loops under one subscription, positioning itself as a data-driven longevity platform rather than a single-product weight-loss service.
Your biology deserves a doctor who reads your data
Visit site
Fellahealth
Fella Health sells physician-supervised weight-loss programs built around GLP-1 medications (compounded semaglutide and tirzepatide), at-home metabolic lab kits, and ongoing telehealth coaching. Packages are priced at a mid-range level—typically $200-$400 per month including medication, consultations, and digital support—and are available only through the brand’s online platform; no retail or pharmacy pickup is required.
The company differentiates itself by focusing exclusively on men with a BMI ≥30, pairing prescription medication with testosterone optimization and strength-centric lifestyle plans. All treatment plans are written by U.S.-licensed physicians, shipped in discreet packaging, and supported by a mobile app that tracks biomarkers, nutrition, and workout data, creating a data-driven, masculine frame around medical weight loss.
Core customers are 25-55-year-old men who have plateaued with diet and exercise alone, value privacy, and prefer a tech-enabled, pharma-grade solution over in-person clinics. The brand speaks to performance, convenience, and scientific credibility, appealing to guys who want to lose visceral fat while preserving muscle and avoiding “diet-culture” messaging.
Fella competes with national telehealth weight-loss platforms and men’s wellness clinics that prescribe GLP-1 drugs. It separates itself by narrowing the audience to men, bundling testosterone screening, emphasizing strength outcomes rather than scale weight, and pricing below traditional concierge medical practices while offering faster onboarding than hospital-based programs.
Lose fat, keep muscle, skip the clinic visits entirely
Visit site
Joinweightcare
Joinweightcare is a direct-to-consumer, online-only wellness platform that bundles prescription GLP-1 weight-loss medications (compounded semaglutide and tirzepatide) with telehealth consults, at-home lab kits, and digital coaching. Medication plans start around $199 for the first month and move to $299–$399 per month thereafter, placing the brand in the mid-range tier below big-pharma list prices but above discount peptide sites. All orders are fulfilled by partner compounding pharmacies and shipped to 40+ U.S. states after an asynchronous doctor approval.
The company’s core promise is “prescription + support in one click”: patients complete a 5-minute intake, receive same-day provider review, and get ongoing dose adjustments without leaving the app. Every subscription includes unlimited messaging with the prescribing clinician, a smart-scale integration, and a calorie-tracking app at no extra cost. This bundled model has produced a 4.8/5 Trustpilot rating and a cohort where 78 % of members report ≥10 % body-weight reduction within six months.
Typical buyers are 30-55-year-old professionals—predominantly women—who have BMI ≥27 and have cycled through commercial diets without lasting results. They value medical legitimacy, privacy (no in-person visits), and predictable cash pricing that avoids insurance denials. The brand speaks in clinical but encouraging tones, emphasizing metabolic health over vanity metrics.
Joinweightcare competes with telehealth pill-and-shot startups, cash-pay med-spas, and traditional weight-loss programs. It differentiates by combining compounded GLP-1 access with continuous clinician oversight and behavioral tools under one flat monthly fee, eliminating the need for separate pharmacy, coaching, and lab invoices.
Your doctor, your medication, your coach, all month long
Visit site
Shedrx
Shedrx is a direct-to-consumer telehealth brand that prescribes and ships GLP-1 receptor-agonist weight-loss medications (semaglutide and tirzepatide) and complementary metabolic-support supplements. All care is handled online through a virtual consultation, prescription, and monthly subscription that lands between mid-range and premium pricing—typically $299-$399 for a 4-week compounded injectable supply. The company operates exclusively online; no physical pharmacies or clinics are involved.
The brand’s core edge is speed-to-treatment: most patients complete intake, provider review, and pharmacy dispatch within 48 hours, with medication arriving cold-shipped to their door. Shedrx formulates its own compounded versions of the active ingredients, allowing it to stay in stock during national shortages and to offer dose-titration packs that larger drug-makers do not. A mobile dashboard tracks dosage, side-effects, and progress, reinforcing adherence and data-driven adjustments.
The typical buyer is a 30-55-year-old U.S. resident with a BMI ≥27 who wants physician-guided weight loss without insurance hurdles or in-person visits. Convenience, discretion, and a “life-hack” mindset drive the purchase; customers value being able to start therapy quickly while still under clinician oversight rather than relying on lifestyle apps alone.
Shedrx competes in the fast-growing tele-weight-loss segment populated by digital clinics and wellness subscription services. It differentiates through guaranteed compounded-drug availability, transparent flat pricing, and integrated progress tracking, positioning itself as a faster, more reliable alternative to both traditional insurance-based programs and generic online pharmacies.
Weight loss that actually ships faster than your excuses
Visit site
MyDietDoc
MyDietDoc sells physician-supervised weight-loss programs delivered 100 % online. Core offerings include compounded GLP-1 medications (semaglutide and tirzepatide), metabolic testing kits, and monthly telehealth coaching subscriptions; prices sit in the mid-to-premium tier, typically $250-$450 per month before insurance.
The brand differentiates by pairing every patient with a U.S.-licensed clinician who prescribes and titrates medication without requiring in-person visits, then ships medication from an affiliated compounding pharmacy within 3-5 days. All plans include unlimited messaging, nutrition tracking, and dose adjustments, positioning MyDietDoc as a turnkey medical pathway rather than a supplement or diet plan.
Primary buyers are busy professionals aged 25-55 with 30+ lbs to lose who want clinically proven results but lack time for brick-and-mortar clinics; they value privacy, speed, and medical oversight over flashy lifestyle branding. Messaging emphasizes science, safety, and sustainable weekly fat loss rather than cosmetic quick fixes.
MyDietDoc competes with telehealth GLP-1 startups, cash-pay medical weight-loss chains, and direct-to-consumer supplement brands. It separates itself by bundling prescription authority, personalized titration, and ongoing physician access into one flat monthly fee, avoiding the upsell tiers common among competitors while remaining fully virtual.
Your doctor adjusts your medication while you live your life
Visit site
Portal Shedrx
Portal Shedrx is an online-only telehealth brand that prescribes and ships GLP-1 receptor agonist weight-loss medications—primarily compounded semaglutide and tirzepatide—directly to patients. After a $49 virtual consultation, qualifying customers receive monthly subcutaneous injection kits priced at $199–$399, placing the offer in the mid-range between discount compounding pharmacies and premium brick-and-mortar clinics. All prescriptions are filled through partnered U.S. compounding pharmacies and delivered in temperature-controlled packaging.
The company’s core edge is a fully digital, subscription-based model that bundles provider consults, dosage titration support, and medication into one recurring shipment. Each patient is assigned a clinician who monitors progress via a HIPAA-compliant portal, and refills are automatically calibrated to the individual’s titration schedule. This integrated “prescription-to-doorstep” system lets users avoid retail pharmacies and in-office visits while still accessing the same active ingredients found in higher-priced name-brand injectables.
Typical buyers are 25-55-year-old U.S. residents with a BMI ≥27 who want clinically significant weight loss without insurance hurdles or time-consuming clinic appointments. The brand speaks to value-driven, tech-savvy consumers who prioritize convenience, privacy, and transparent cash pricing over traditional healthcare rituals.
Portal Shedrx competes with telehealth platforms, med-spa chains, and cash-pay compounding pharmacies that market similar GLP-1 programs. It differentiates by combining proprietary clinician oversight, fixed monthly pricing that includes medication, and an interface that automates dose adjustments—delivering a more cohesive, app-managed experience than piecemeal prescription or injection services.
Weight loss that actually fits your life, delivered to your door
Visit site